Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02448186
Other study ID # 1306012230
Secondary ID
Status Completed
Phase N/A
First received April 15, 2015
Last updated May 14, 2015
Start date July 2012
Est. completion date December 2014

Study information

Verified date May 2015
Source Yale University
Contact n/a
Is FDA regulated No
Health authority United States: National Institute of Health
Study type Interventional

Clinical Trial Summary

The proposed study will adapt a cognitive behavioral intervention to support high-risk MSM's adaptive coping with minority stress, alleviate associated depression and anxiety, and reduce HIV risk behavior. The adapted intervention is expected to increase awareness of the unhealthy impact of minority stress; facilitate objective self-schemas in the face of minority stress; and strengthen one's skills and self-efficacy for managing minority stress and associated anxiety and depression to reduce risk for acquiring HIV.


Description:

Gay, bisexual, and other men who have sex with men (MSM) are the population most severely affected by HIV in the U.S. and one of the only risk groups in the U.S. for which new infections continue to rise. MSM also experience a vastly disproportionate risk of mental health disorders, especially depression and anxiety. Numerous studies have shown that this mental health disparity arises from the early and ongoing stressors, known as minority stress, that MSM experience related to their sexual orientation. Despite the fact that minority stress is strongly related to anxiety and depression, and that minority stress and related mental health problems synergistically propel HIV risk behaviors, no existing HIV prevention intervention targets minority stress in order to reduce MSM's HIV risk behavior. This project aims to develop a theoretically-driven intervention that reduces the health-depleting effects of minority stress through targeting the basic psychosocial mechanisms linking minority stress to HIV risk behavior. These mechanisms include maladaptive emotion regulation, negative thinking styles, low self-efficacy, avoidance, and impulsivity, which are the very targets of an existing cognitive-behavioral, manualized intervention--the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders (UPTTED). The UPTTED changes these mechanisms using motivational interviewing, interoceptive and situational exposure, cognitive restructuring, mindfulness, and self-monitoring exercises, all grounded in cognitive-behavioral principles and developmental and affective neuroscience models of stress. The proposed study will adapt the UPTTED to support high-risk MSM's adaptive coping with minority stress, alleviate associated depression and anxiety, and reduce HIV risk behavior. The adapted UPTTED is expected to increase awareness of the unhealthy impact of minority stress; facilitate objective self-schemas in the face of minority stress; and strengthen one's skills and self-efficacy for managing minority stress and associated anxiety and depression to reduce risk for acquiring HIV. MSM who have experienced minority stress, mental health problems, and HIV risk behavior in the previous 3 months (n = 30) and community health experts (n = 30) will provide suggestions for adaptations to the existing intervention manual, including culturally relevant vignettes, examples, and exercises for adaptively responding to minority stress and managing HIV risk. The feasibility, acceptability, and preliminary efficacy of the adapted intervention will then be tested in a randomized waitlist controlled trial with MSM (n = 60) who report recent experiences with minority stress, depression and anxiety, and HIV risk behavior. The primary outcome will be HIV risk behavior. Secondary outcomes will be reductions in mediators including depression, anxiety, and the mechanisms of the conceptual model. This project innovatively seeks to test the preliminary efficacy of the first theoretically-driven intervention targeting the mental and sexual health consequences of minority stress and does so by targeting the underlying mechanisms that powerfully drive these simultaneous health threats.


Recruitment information / eligibility

Status Completed
Enrollment 63
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

1. Subjective stress related to sexual identity over the previous three months;

2. Symptoms of depression or anxiety within the past three months;

3. HIV sexual risk behavior (one or more acts of condomless insertive or receptive anal sex with a male partner of unknown or discordant serostatus) within the past three months;

4. Biological male gender;

5. At least 18 years of age;

6. Not known to have HIV;

7. Residential stability and availability for six months;

8. Ability to communicate in English; and

9. Provision of informed consent.

Exclusion Criteria:

1. active, unmedicated symptoms of bipolar I or bipolar II disorder or any Diagnostic and Statistical Manual-IV psychotic disorder in the past 12 months;

2. Current suicidal or homicidal ideation;

3. Evidence of gross cognitive impairment;

4. Current enrollment in an HIV-related intervention or research study; and

5. Knowledge of being infected with HIV.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
ESTEEM
10-session cognitive behavioral treatment

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Yale University Hunter College

References & Publications (1)

Pachankis JE. Uncovering Clinical Principles and Techniques to Address Minority Stress, Mental Health, and Related Health Risks Among Gay and Bisexual Men. Clin Psychol (New York). 2014 Dec;21(4):313-330. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary reductions in the number of condomless anal sex acts in the past 90 days with HIV-positive or HIV-status-unknown male partners 3 months No
Secondary reduction in depression severity as measured with the Center for Epidemiological Studies Depression Scale 3 months No
Secondary reduction in anxiety severity as measured with the Overall Anxiety Severity & Impairment Scale 3 months No
Secondary reduction in minority stressors as measured with the Sexual Orientation Concealment Scale 3 months No
Secondary reductions in psychological risk factors measured with the Ruminative Responses Scale 3 months No
Secondary reductions in number of days in which heavy alcohol and potentially harmful recreational substances were use 3 months No
Secondary among individuals with body image disturbance, improvements in body attitudes as measured with the Male Body Attitude Scale 3 months No
Secondary among individuals with sexual compulsivity, reduction in sexual compulsivity severity as measured with the Sexual Compulsivity Scale 3 months No
Secondary reduction in alcohol use problems as assessed with the Alcohol Use Disorders Identification Test 3 months No
Secondary in participants with generalized anxiety disorder, reduction in Penn State Worry Questionnaire 3 months No
Secondary reduction in depression severity as measured with the Overall Depression Severity & Impairment Scale 3 months No
Secondary reduction in anxiety severity as measured with the State Trait Anxiety Inventory (State subscale) 3 months No
Secondary reduction in minority stressors as measured with the Internalized Homophobia Scale 3 months No
Secondary reduction in minority stressors as measured with the Rejection Sensitivity Scale 3 months No
Secondary reductions in psychological risk factors measured with the Rathus Assertiveness Schedule 3 months No
Secondary reductions in psychological risk factors measured with the Difficulties of Emotion Regulation Scale 3 months No
Secondary reductions in psychological risk factors measured with the Multidimensional Scale of Perceived Social Support 3 months No
Secondary in participants with obsessive-compulsive disorder, reductions in the Yale-Brown OC Scale 3 months No
Secondary in participants with panic disorder, reduction in the Panic Disorder Severity Scale 3 months No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A